Table 2.
End point | Terlipressin n (%) | Placebo n (%) | P value |
---|---|---|---|
All patients | (n = 56) | (n = 56) | |
Treatment success at day 14 | 14 (25.0) | 7 (12.5) | .093 |
HRS reversal | 19 (33.9) | 7 (12.5) | .008 |
Patients who received >3 days of treatment | (n = 36) | (n = 39) | |
Treatment success at day 14 | 14 (38.9) | 7 (17.9) | .046 |
HRS reversal | 19 (52.8) | 7 (17.9) | .002 |